ISRCTN93681536已完成不适用
A randomised controlled trial of different methods of alcohol screening and brief interventions in routine accident and emergency department care
Institute of Psychiatry, Kings College London (UK)0 个研究点目标入组 1,179 人开始时间: 2007年6月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,179
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. AED patients
- •2. Scoring positive on the Paddington Alcohol Test (PAT), FAST or SASQ
- •3. Patients who are alert and orientated
- •4. Aged 18 or over, either sex
- •5. Able to speak English sufficiently well to complete study questionnaires
排除标准
- •1. Already in contact with alcohol services
- •2. Those already included in the study
- •3. Those requesting help with alcohol problems at a tertiary level
研究者
相似试验
已完成
不适用
Assessing the effectiveness of methods to recruit schools to an app-based nutrition program.ACTRN12619000506190niversity of Newcastle70
已完成
不适用
A randomised controlled trial of different intensities of physiotherapy and collaborative goal-setting in children with cerebral palsy.Nervous System DiseasesCerebral palsyISRCTN88897355Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)56
进行中（未招募）
不适用
Randomised controlled trial evaluating strategies to optimize disease activity control in RA patients treated with infliximab in clinical practice. - Re3Adult subjects with a diagnosis of Rheumatoid Arthritis presenting with a disease flare after an initial response to infliximabMedDRA version: 8.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2005-001889-13-SESchering-Plough Research Institute, a division of Schering Corporation315
尚未招募
3 期
Randomised controlled trial evaluating strategies to optimize disease activity control in RA patients treated with infliximab in clinical practice.Arthritis10023213Rheumatoid ArthritisNL-OMON29750Schering-Plough36
进行中（未招募）
不适用
Randomised controlled trial evaluating strategies to optimize disease activity control in RA patients treated with infliximab in clinical practice. - RE3Adult subjects with a diganosis of Rheumatoid Arthritis presenting with a disease flare after an initial response to infliximab.MedDRA version: 8.1Level: LLTClassification code 10060732Term: Rheumatoid arthritis flare upEUCTR2005-001889-13-DKIntegrated Therapeutics Group, Inc. - A subsidiary of Schering-Plough Corp.315